New drug SUVN-I6107 takes first step in human testing
NCT ID NCT06705088
First seen Jan 04, 2026 · Last updated May 23, 2026 · Updated 25 times
Summary
This early-stage study tested a new drug called SUVN-I6107 in 64 healthy adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo as a single dose or multiple doses. Researchers also checked for changes in brain activity using EEG tests. The goal was to gather basic safety and drug behavior information before testing in patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Research Site
San Antonio, Texas, 78209, United States
Conditions
Explore the condition pages connected to this study.